PDS Biotechnology
(NASDAQ) PDSB
PDS Biotechnology Financials at a Glance
Market Cap
$35.55M
Revenue (TTM)
$0.00
Net Income (TTM)
$34.88M
EPS (TTM)
$-0.82
P/E Ratio
-0.79
Dividend
$0.00
Beta (Volatility)
1.94 (High)
Dividend
$0.00
Beta (Volatility)
1.94 (High)
Price
$0.62
Volume
1,574
Open
$0.61
Price
$0.62
Volume
1,574
Open
$0.61
Previous Close
$0.62
Daily Range
$0.60 - $0.63
52-Week Range
$0.60 - $1.92
Dividend
$0.00
Beta (Volatility)
1.94 (High)
Price
$0.62
Volume
1,574
Open
$0.61
Previous Close
$0.62
Daily Range
$0.60 - $0.63
52-Week Range
$0.60 - $1.92
PDSB News
PDSB: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout PDS Biotechnology
Industry
Biotechnology
Sector
Health CareEmployees
24
CEO
Frank K. Bedu-Addo, PhD
Website
www.pdsbiotech.comHeadquarters
Princeton, NJ 07932, US
PDSB Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-222%
Return on Capital
-2%
Return on Assets
-1%
Earnings Yield
-1.27%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$35.55M
Shares Outstanding
54.72M
Volume
1.57K
Short Interest
0.00%
Avg. Volume
586.50K
Financials (TTM)
Gross Profit
$59.79K
Operating Income
$36.32M
EBITDA
$33.75M
Operating Cash Flow
$35.03M
Capital Expenditure
$29.00K
Free Cash Flow
$35.06M
Cash & ST Invst.
$41.69M
Total Debt
$21.83M
PDS Biotechnology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$35.55M
N/A
Market Cap/Employee
$1.48M
N/A
Employees
24
N/A
Net Income
$9.01M
+16.0%
EBITDA
$7.86M
+17.3%
Quarterly Fundamentals
Net Cash
$8.23M
-67.2%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$11.92M
-1.5%
Short Term Debt
$6.04M
-51.9%
Return on Assets
-1.01%
N/A
Return on Invested Capital
-1.51%
N/A
Free Cash Flow
$5.92M
+26.0%
Operating Cash Flow
$5.92M
+26.0%